arsenic trioxide has been researched along with Endometrial Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, K; Fujii, N; Maeda, Y; Matsuoka, H; Matsuoka, KI; Nakamura, K; Nishimori, H; Sugiura, H | 1 |
| Cai, H; Li, X; Wang, J | 1 |
| Bae-Jump, VL; Boggess, JF; Gehrig, PA; Zhou, C | 1 |
| Bae-Jump, V; Boggess, JF; Gehrig, PA; Zhou, C | 1 |
1 review(s) available for arsenic trioxide and Endometrial Neoplasms
| Article | Year |
|---|---|
Arsenic trioxide in the treatment of platinum-resistant recurrent endometrial cancer: a case report and literature review.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Arsenic Trioxide; Endometrial Neoplasms; Female; Humans; Neoplasm Recurrence, Local | 2020 |
3 other study(ies) available for arsenic trioxide and Endometrial Neoplasms
| Article | Year |
|---|---|
Successful Treatment of Acute Promyelocytic Leukemia Complicated with Endometrial Cancer by Arsenic Trioxide.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Arsenic Trioxide; Endometrial Neoplasms; Female; Humans; Leukemia, Promyelocytic, Acute | 2021 |
Arsenic trioxide (As2O3) inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase (MAPK) pathway in endometrial cancer cells.
Topics: Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Endometrial Neoplasms; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Oxides | 2008 |
Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Growth Processes; Cell Line, Tumor; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Flow Cytometry; Humans; Oxides; RNA, Messenger; Telomerase | 2007 |